Mobile app version of munafa.us
Login or Join
 Learn then Earn
stockMarketNEWS

 story : : Sanofi to cap price of Lantus insulin at #FinanceUSA #StockMarketNEWS Sanofi SNYFR:SAN said Thursday that it will cut the U.S. list price of Lantus by 78%, and it will also cap out-of-pocket

@stockMarketNEWS 12 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

: Sanofi to cap price of Lantus insulin at #FinanceUSA #StockMarketNEWS
Sanofi SNYFR:SAN said Thursday that it will cut the U.S. list price of Lantus by 78%, and it will also cap out-of-pocket costs at for the same insulin for people with commercial health insurance, starting in 2024. The French drugmaker’s announcement follows the reduction of insulin prices at Eli Lilly LLY and Novo Nordisk NVODK:NOVO.B. Sanofi said Lantus is its most widely prescribed insulin. U.S.-listed shares of Sanofi are down 0.6% so far this year, while the S&P 500 SPX is up 1.7%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme